Skip to main content
. 2018 Mar 8;3(3):e000320. doi: 10.1136/esmoopen-2018-000320

Table 1.

Baseline characteristics: subgroups according to Crea-Cl (median; range)

Crea-Cl <125 mL/min
n=36
Crea-Cl >125 mL/min
No dose capping, n=29
Age (years) 47 (22–71) 33 (23–53) P=0.0001
SCr (μmol/L) 79 (51–117) 77 (52–92) NS
Crea-Cl (mL/min) 109 (70–120)* 143 (125–184)*
Carboplatin dose (g) 950 (700–1020)* 1200 (1050–1480)*

*Significant differences due to definition of subgroup.

Crea-Cl, creatinine-clearance; SCr, serum-creatinine.